세계의 정형외과용 수탁제조 시장 규모, 점유율, 동향 분석 : 유형별·서비스별, 지역별, 부문별 예측(2025-2033년)

Orthopedic Contract Manufacturing Market Summary

The global orthopedic contract manufacturing market size was estimated at USD 11.01 billion in 2024 and is projected to reach USD 33.20 billion by 2033, growing at a CAGR of 13.49% from 2025 to 2033. The orthopedic contract manufacturing market is gaining momentum owing to increasing prevalence of musculoskeletal disorders, an aging population, and a rising demand for advanced orthopedic implants and instruments.

Further, the growing advancements in materials science, additive manufacturing, and precision machining, the production of highly customized and minimally invasive devices is expected to drive the market growth, as it aligns with patient-specific treatments. Additionally, increasing cost pressures on original equipment manufacturers (OEMs) and the need to accelerate their time-to-market have led to greater reliance on external manufacturing partners supporting market growth. Furthermore, the shift toward value-based healthcare models emphasizes the need for high-quality, cost-effective orthopedic solutions.

In the orthopedic market, contract manufacturing has become essential for large-scale and specialized production of orthopedic products. Manufacturers increasingly rely on contract manufacturing partners for their technical expertise, advanced production capabilities, and compliance with regulatory standards. This outsourcing approach allows OEMs to focus on their core strengths, such as research and development, clinical validation, and market expansion, while also reducing capital expenditure and streamlining operational complexities.

Furthermore, increasing demand for joint reconstruction, trauma fixation, spinal implants, and sports medicine devices due to a rising orthopedic disease burden and higher accident rates has intensified the need for efficient, high-volume orthopedic manufacturing. Additionally, timely supply, consistent quality, and the ability to scale in response to market changes have driven the trend of outsourcing in the orthopedic industry.

Furthermore, recent technological advancements in orthopedic contract manufacturing include the integration of additive manufacturing, advanced CNC machining, robotics, and AI-powered quality control systems. These innovations have made it possible to produce highly precise, customized implants and instruments with shorter lead times. Improved biomaterial processing capabilities, such as titanium alloys and bioresorbable polymers, have further enhanced device performance and patient outcomes. Automation and digital manufacturing platforms have increased production efficiency, reduced errors, and strengthened compliance with strict regulatory and quality standards.

Global Orthopedic Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global orthopedic contract manufacturing market report based on type, service, and region.

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Implants
• Instruments
• Cases
• Trays
• Service Outlook (Revenue, USD Million, 2021 - 2033)
• Forging/Casting
• Hip Machining & Finishing
• Knee Machining & Finishing
• Spine & Trauma
• Instrument Machining & Finishing
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Services
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Top-Down Analysis
  • 1.7.3. Botton-Up Approach
  • 1.7.4. Multivariate Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Orthopedic Contract Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Aging Population & Rising Musculoskeletal Disorders
    • 3.2.1.2. Rising Technological Advancements
    • 3.2.1.3. Growing Cost Efficiency & Outsourcing Trends
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Industry Consolidation and Backward Integration
    • 3.2.2.2. Stringent Regulatory and Quality Compliance Requirements
• 3.3. Technology Landscape
• 3.4. Pricing Model Analysis
• 3.5. List of Orthopedic Products Approvals, 2024
• 3.6. Tariff Impact Analysis
• 3.7. Value Chain Analysis
  • 3.7.1. Supply Trends
  • 3.7.2. Demand Trends
• 3.8. Market Analysis Tools
  • 3.8.1. Porter's Five Force Analysis
  • 3.8.2. PESTEL by SWOT Analysis

Chapter 4. Orthopedic Contract Manufacturing Market: Type Estimates & Trend Analysis

• 4.1. Orthopedic Contract Manufacturing Market, By Type: Segment Dashboard
• 4.2. Orthopedic Contract Manufacturing Market, By Type: Movement Analysis
• 4.3. Orthopedic Contract Manufacturing Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
• 4.4. Implants
  • 4.4.1. Implants Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Instruments
  • 4.5.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Cases
  • 4.6.1. Cases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Trays
  • 4.7.1. Trays Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Orthopedic Contract Manufacturing Market: by Service Estimates & Trend Analysis

• 5.1. Orthopedic Contract Manufacturing Market, by Service: Segment Dashboard
• 5.2. Orthopedic Contract Manufacturing Market, by Service: Movement Analysis
• 5.3. Orthopedic Contract Manufacturing Market Estimates & Forecasts, by Service, 2021 - 2033 (USD Million)
• 5.4. Forging/Casting
  • 5.4.1. Forging/Casting Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Hip Machining & Finishing
  • 5.5.1. Hip Machining & Finishing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Knee Machining & Finishing
  • 5.6.1. Knee Machining & Finishing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Spine & Trauma
  • 5.7.1. Spine & Trauma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Instrument Machining & Finishing
  • 5.8.1. Instrument Machining & Finishing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Orthopedic Contract Manufacturing Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Dashboard
• 6.2. Regional Market Share Analysis, 2024 & 2033
• 6.3. North America
  • 6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2. U.S
    • 6.3.2.1. Key Country Dynamics
    • 6.3.2.2. Competitive Scenario
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.3. Canada
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Competitive Scenario
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.4. Mexico
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Competitive Scenario
    • 6.3.4.3. Regulatory Framework
    • 6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Europe
  • 6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. UK
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Germany
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. France
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.5. Italy
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Competitive Scenario
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.6. Spain
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Competitive Scenario
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.7. Denmark
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Competitive Scenario
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.8. Sweden
    • 6.4.8.1. Key Country Dynamics
    • 6.4.8.2. Competitive Scenario
    • 6.4.8.3. Regulatory Framework
    • 6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.9. Norway
    • 6.4.9.1. Key Country Dynamics
    • 6.4.9.2. Competitive Scenario
    • 6.4.9.3. Regulatory Framework
    • 6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Asia Pacific
  • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.2. Japan
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.3. China
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.4. India
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.5. Australia
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.6. Thailand
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5.7. South Korea
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Latin America
  • 6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2. Brazil
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.3. Argentina
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. MEA
  • 6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.2. South Africa
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.3. UAE
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.4. Saudi Arabia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.5. Kuwait
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.6. Qatar
    • 6.7.6.1. Key Country Dynamics
    • 6.7.6.2. Competitive Scenario
    • 6.7.6.3. Regulatory Framework
    • 6.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7.7. Oman
    • 6.7.7.1. Key Country Dynamics
    • 6.7.7.2. Competitive Scenario
    • 6.7.7.3. Regulatory Framework
    • 6.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Key Participant Categorization
  • 7.1.1. Market Leaders
  • 7.1.2. Emerging Players
• 7.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
• 7.3. Company Profiles
  • 7.3.1. Tecomet, Inc
    • 7.3.1.1. Company Overview
    • 7.3.1.2. Financial Performance
    • 7.3.1.3. Service Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. Orchid Orthopedic Solutions
    • 7.3.2.1. Company Overview
    • 7.3.2.2. Financial Performance
    • 7.3.2.3. Service Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. Cretex companies
    • 7.3.3.1. Company Overview
    • 7.3.3.2. Financial Performance
    • 7.3.3.3. Service Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. Viant
    • 7.3.4.1. Company Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Service Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. ARCH Medical Solutions Corp.
    • 7.3.5.1. Company Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Service Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Avalign Technologies
    • 7.3.6.1. Company Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Service Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. LISI Medical
    • 7.3.7.1. Company Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Service Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. Paragon Medical
    • 7.3.8.1. Company Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Service Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Norman Noble, Inc.
    • 7.3.9.1. Company Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Service Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. Autocam Medical
    • 7.3.10.1. Company Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Service Benchmarking
    • 7.3.10.4. Strategic Initiatives